Hyperscale and edge computing infrastructure serving AI, cloud and enterprise demand. Non-replicable location with secured power access. Full details under NDA.
Solar and grid infrastructure with secured PPA. Grid connection and permits in place. Actively sourcing additional energy projects — solar parks, storage systems, grid assets.
Strategic land, logistics real estate, and physical enablers with non-replicable locations and long-term lease structures.
· Helvetic Immobilien Group — CHF 300M Portfolio (valued by Wüest & Partner), CHF 580M development pipeline. Banking partners: Quirin, ING, BNP.
· Pneu Bösigter AG (part of Helvetic Group) — Subordinated bond CHF 8M, 6.75% p.a.
· Etlibe AG — Commercial property Opfikon, CHF 8M, 4.4% net initial yield (increase to 7.1% possible at market rent).
· Microspaces Aarau (IBS) — Micro-living / small commercial spaces.
· Bauclub AG — Development & general planning.
Treatment, distribution and resource management systems addressing pesticide contamination, privatised sources, and climate-driven scarcity. Only ~30% of surface water usable.
Applied AI in real asset operations and digital backbone for future infrastructure.
· Summix AG — Digital infrastructure.
Direct ownership of LBMA-certified gold stored in Swiss non-bank vaults. Central banks have bought gold for 15 consecutive years; the twin shock of supply-chain inflation and AI-driven job losses accelerates the flight to physical. Actively accumulating for the firm's own book and for qualified investors.
GIA-certified coloured and D‑flawless diamonds sourced directly from cutting centres. Diamonds serve as a portable, sovereign-risk-free store of value with low correlation to financial markets. Actively building a curated inventory for qualified investors.
Sustainable air filter technology removing 99.9% of harmful air particles over 10 years. Expansion into Dubai/KSA. Market of USD 200–400 billion by 2040, driven by air quality regulation.
Wound treatment with LOI from Coloplast (DKK 27B global player). China clinical study: 90% healing within 84 days vs. 50% standard of care. MDR Class IIb, patents US/EU, exit target 2028 via trade sale.
Multiple opportunities currently passing through initial screening. Names and details withheld pending NDA or further due diligence. Enquiries welcome.
Kamenica Capital focuses on a limited number of deals at any given time. If your project fits our structural scarcity framework — energy, water, food security, critical minerals, or the hard assets that protect purchasing power — we look forward to hearing from you.